Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
Prometic Life Sciences Inc.
Volgen
winx09 schreef op 16 april 2019 08:26 :
geen idee. Maar de grote jongens krijgen oneindig veel aandelen voor die 0.01521. Mijn persoonlijke mening gebaseerd op blaren uit het verleden: blijf weg bij dit soort toko´s. De pijplijn gaat in brokjes verkocht worden (@Hoekema wellicht goedkoop IP te kopen rondom IPF ?). Voor de speculant wellicht wel interessant want er zullen extreme koersbewegingen gaan plaats vinden. Uiteindelijk schrapen de grote jongens nog een deel van hun verlies bij elkaar en kunnen de kleine aandeelhouders fluiten naar hun centen.
Bovenstaande niet op basis van diepgaande kennis van Prometic, maar het patroon is voor mij duidelijk.
succes met je afweging.
Wellicht willen er bij Galapagos nog een keer naar kijken als het echt heel goedkoop binnen valt te halen. Ik heb Hoekema er bij de nieuwjaarsborrel naar gevraagd maar toen gaf hij aan er wel naar gekeken te hebben maar het niet interessant te vinden (Galapagos had zelf betere moleculen).
FatCool schreef op 19 april 2019 13:40 :
En we beginnen alvast per onmiddellijk: blijf weg van alles wat genoteerd staat op de Canadese Venture en TSX markten!!!!!
Dramatic dilution at Prometic Life Sciences draws ire of shareholders Toronto Stock Exchange granted the company’s application to go ahead without a shareholder vote due to 'financial hardship' Some shareholders of a Quebec-based biotechnology company are objecting to a dilutive restructuring that wipes out most of their equity in Prometic Life Sciences Inc., a transaction they didn’t get to vote on because the Toronto Stock Exchange granted the company’s application to go ahead without a shareholder vote due to “financial hardship.” “We’re being just driven into oblivion here,” Jean Pierre Toupin, a 72-year-old editor and former economist who has been an investor in Prometic for about five years, told the Financial Post on Tuesday. But Laval-based Prometic, which boasted a spot in the benchmark S&P/TSX Composite Index until last June and investors including the California Public Employees’ Retirement System (CalPERS), said the transactions were the only viable option to reduce the firm’s debt burden and interest payments, and provide some cash to continue operations following a series of setbacks. The biotech firm is developing a process to separate plasma proteins to treat orphan illnesses, but stumbled following a delayed U.S. Food and Drug Administration (FDA) approval, as well as a delay in receiving a research and development tax credit reimbursement from the United Kingdom. The chief executive was replaced late last year, and the company would have breached covenants under its credit facilities with SALP on March 31 if not granted a waiver. Following a $229 million debt-to-equity conversion and a private placement completed Tuesday, Thomvest Asset Management affiliate Structured Alpha LP jumped from owning or controlling just 3.6 per cent to more than 80 per cent of Prometic’s issued and outstanding common shares. Thomvest Asset Management is a private investment firm controlled by Peter J. Thomson, a member of Canada’s richest family and a board member at Thomson Reuters. “Mr. Thomson is aware of the Prometic investment but has no day-to-day involvement in managing or overseeing the investment and was not involved in negotiating or implementing the Prometic restructuring transactions,” according to a spokesperson for Thomvest. The private placement at Prometic, which included issuing shares to Consonance Capital Management, raised $75 million, which will be used “to fund working capital needs and for general corporate purposes including the advancement of its drug discovery platforms,” according to a news release issued by Prometic on April 15. In the same release, Prometic said it had hired investment banks and taken steps to try to refinance, sell non-core assets, or forge partnerships to shore up operations, but no other viable option could be brought to fruition in time to steady the heavily leveraged company. The decision to rely on the financial hardship exemption — which meant the plan would not be put to a shareholder vote — was made following a recommendation by a special committee of independent directors whose members were all “free from interest in the Debt Conversion, the Warrant Repricing and the Private Placement, and unrelated to the parties involved in these transactions,” the statement said. But the restructuring is not sitting well with some shareholders who have found their holdings diluted, and they are not consoled by an option to make further investments through a follow-up rights offering. Toupin, who is from Ottawa but is living in Montreal, said he recently connected with a group of investors from across the country who feel much of the company’s promise is being taken out from under existing shareholders by other involved parties. They had urged the Toronto Stock Exchange to reject the requested exemption that allowed the Prometic restructuring to go ahead without a shareholder vote because they wanted more say in the company’s future. “This was part of my retirement money…. It’s a significant loss for me, and it’s probably more dramatic for a lot of other people,” Toupin said, suggesting retail investors could number in the thousands. Prometic shares, which traded at more than $3 apiece in 2016, closed at 6.5 cents on Tuesday. Shareholders have also taken their concerns to regulators that oversee the Toronto Stock Exchange, including Quebec’s Authorité des marchés financiers (AMF). “We have actually received several complaints in this file and we are going to analyze them,” Sylvain Théberge, a spokesperson for the AMF, told the Financial Post in an emailed statement on Tuesday. Théberge declined to comment further. Catherine Kee, manager of corporate communications at TMX Group, parent company of the Toronto Stock Exchange, declined to discuss the Prometic case. “We don’t comment on individual issuer matters,” she said. Mike Osborn, a spokesperson for CalPERS, declined to comment on the situation at Prometic, but confirmed that the largest public pension fund in the United States owned a stake in the Canadian biotech firm at the end of June 2018, the period covered by its most recent annual report. The stake at that time consisted of 1,464,100 shares with a market value US$578,762 and a book value of US$3.38 million. “About the company, we do not have a comment,” he said in an email. On Tuesday, as Prometic announced that the restructuring had gone ahead, the company said it intends to seek approval from its shareholders for a share consolidation at a special meeting in Montreal on June 19. The company now has 20,947,510,578 common shares issued and outstanding on a fully-diluted basis, including all outstanding warrants, stock options and restricted share units. Prometic also installed Kenneth Galbraith as chief executive officer. Galbraith spent 13 years in senior management at QLT Inc., a Vancouver-based biopharmaceutical company that merged with Massachusetts-based Aegerion Pharmaceuticals Inc. in 2016. Simon Best, who had been interim CEO of Prometic, was appointed lead independent director, and Stefan Clulow, managing director and chief investment officer of Thomvest Asset Management, was appointed chair of Prometic’s board of directors.business.financialpost.com/news/fp-st...
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)